AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2026
Awaiting price reaction for this filing.
Citurgia Biochemicals reported zero revenue from operations for both Q4 and full year FY26, while expenses stood at Rs 25.82 Lakhs (Q4) and Rs 74.25 Lakhs (full year). The company posted a net loss of Rs 74.25 Lakhs for FY26, nearly doubling from Rs 42.31 Lakhs loss in FY25. The balance sheet shows severe distress with negative total equity of Rs 773.41 Lakhs (net worth is negative) and accumulated losses of Rs 3,665.32 Lakhs. Inventories remained flat at Rs 806.63 Lakhs. Operating cash flow was negative at Rs 13.09 Lakhs. Despite these issues, the statutory auditor issued an unmodified (clean) opinion.
The company has negative net worth and is generating losses with no revenue. The clean audit opinion despite these red flags may raise questions about transparency. Shareholders face extreme risk as the company appears to be non-operational or in severe financial distress.